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The Journal of Immunology
Eosinophil-Mediated Immune Control of Adult Filarial
Nematode Infection Can Proceed in the Absence of IL-4
Receptor Signaling
Nicolas Pionnier, Hanna Sjoberg, Julio Furlong-Silva, Amy Marriott, Alice Halliday,
John Archer, Andrew Steven, Mark J. Taylor, and Joseph D. Turner
Helminth infections are accompanied by eosinophilia in parasitized tissues. Eosinophils are effectors of immunity to tissue hel-
minths. We previously reported that in the context of experimental filarial nematode infection, optimum tissue eosinophil recruit-
ment was coordinated by local macrophage populations following IL-4R–dependent in situ proliferation and alternative activation.
However, in the current study, we identify that control of chronic adult filarial worm infection is evident in IL-4Ra–deficient
(IL-4Ra2/2) mice, whereby the majority of infections do not achieve patency. An associated residual eosinophilia was apparent in
infected IL-4Ra2/2mice. By treating IL-4Ra2/2mice serially with anti-CCR3 Ab or introducing a compound deficiency in CCR3
within IL-4Ra2/2 mice, residual eosinophilia was ablated, and susceptibility to chronic adult Brugia malayi infection was
established, promoting a functional role for CCR3-dependent eosinophil influx in immune control in the absence of IL-4/IL-
13–dependent immune mechanisms. We investigated additional cytokine signals involved in residual eosinophilia in the absence
IL-4Ra signaling and defined that IL-4Ra2/2/IL-52/2 double-knockout mice displayed significant eosinophil deficiency compared
with IL-4Ra2/2 mice and were susceptible to chronic fecund adult filarial infections. Contrastingly, there was no evidence that
either IL-4R–dependent or IL-4R–independent/CCR3/IL-5–dependent immunity influenced B. malayi microfilarial loads in the
blood. Our data demonstrate multiplicity of Th2-cytokine control of eosinophil tissue recruitment during chronic filarial infection
and that IL-4R–independent/IL-5– and CCR3-dependent pathways are sufficient to control filarial adult infection via an
eosinophil-dependent effector response prior to patency. The Journal of Immunology, 2020, 205: 000–000.
E
osinophilia is a hallmark of the immune response against
helminth parasite infection (1–5). Eosinophils are recruited
to tissue sites of parasitism and have direct targeted
effects on nematode worms, such as degranulation (release of
granule constituents such as cytotoxic molecules or enzymes)
(2, 6, 7), Ab-dependent cytotoxicity capacity (8, 9), or granuloma
formation. The latter is a host protective immune mechanism by
which layers of innate effector cells concatenate around excreting–
secreting pores of the worm to limit worm motility and enhance
effects of granulocyte degranulation (5, 10–12). Neutrophil gran-
ulocytes release extracellular DNA “traps” when in contact with
Litomosoides sigmodontis, Onchocerca volvulus, or Dirofilaria
immitis filarial worms or their endosymbionts, Wolbachia (13–15).
Because eosinophils can also generate extracellular traps (16, 17), it
is postulated that eosinophils may also contribute toward this anti-
filarial effector immune response.
The mechanisms coordinating eosinophil recruitment to the site
of infection remain to be resolved. In a previous investigation, we
reported that macrophages polarized to an alternatively activated
phenotype through IL-4R activation mediated immunity to the
human lymphatic filarial pathogen, Brugia malayi, by sustaining a
vigorous CCR3-dependent eosinophilia at the site of infection
(18). We demonstrated that this mechanism substantially influ-
enced numbers of infectious-stage larvae surviving to the imma-
ture adult developmental stage.
In the current study, we explored the long-term consequences of
IL-4Ra deficiency and degree of eosinophil recruitment on B.
malayi filarial parasitism using a typically nonpermissive BALB/c
mouse model of infection and additional IL-5 and CCR3 com-
pound deficiencies.
Materials and Methods
Mice, infections, and treatments
BALB/c male mice were purchased from Charles River Laboratories.
BALB/c IL-4R chain a knockout (IL-4Ra2/2) and CCR32/2 mice were
purchased from The Jackson Laboratory. BALB/c IL-4Ra2/2/CCR32/2
double-knockout mice were created by crossing IL-4Ra2/2 and CCR32/2
mice. BALB/c IL-4Ra2/2/IL-52/2 mice were a gift from Professor A.
Hoerauf, University Hospital Bonn. Meriones unguiculatus (Mongolian
gerbils) were originally purchased from Charles River Laboratories. All
knockout mouse lines and gerbils were subsequently bred in-house.
All animals were maintained in specific pathogen-free conditions at the
Centre for Drugs and Diagnostics, Department of Tropical Disease Biology, Liver-
pool School of Tropical Medicine, Liverpool L3 5QA, United Kingdom
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University of Liverpool Biological Services Unit. The experimental life
cycle of B. malayi was maintained by passage between i.p. infections of
male gerbils and membrane-feeding of Liverpool strain Aedes aegypti
mosquitoes, as previously described (19), to provide infectious third-stage
larvae or microfilariae (mf) for infections.
Groups of between four and six mice of 6–10 wk of age were used for
experimental infections. B. malayi third-stage larvae were counted in
batches of 50 in RPMI medium and inoculated via i.p. injection (IP) as
previously described (19). Certain mouse groups were treated with either
0.1 mg rat IgG IP (control) or 0.5 mg anti-aCCR3 Ab (clone: 6S2-19-4;
Bio X Cell) IP to deplete CCR3+ eosinophils. All experiments on animals
were approved by the ethical committees of Liverpool School of Tropical
Medicine and the University of Liverpool and were conducted according to
Home Office Legislation, the revised Animals (Scientific Procedures) Act
of 1986, and Animal Research: Reporting of In Vivo Experiments guide-
lines. B. malayi mf were purified from the peritoneal washings of infected
gerbils as previously described (19). B. malayi mf were concentrated by
centrifugation and resuspended at a density of 1.25 3 106/ml in RPMI
medium before batches of 0.25 3 106 were infused i.v. via the tail vein.
Parasites and cells collection
Motile B. malayi adult stage parasites and peritoneal exudate cells were
recovered by peritoneal lavage at necropsy and worms were enumerated by
microscopy. At $11 wk postinfection, peritoneal mf numbers were de-
termined through peritoneal lavage with 1 ml RPMI and total mf count in a
10-ml suspension.
Presence of mf in the peripheral circulation or in the cardiopulmonary
system of infused mice was detected through thick smears and subsequent
Giemsa staining as previously described (20). Briefly, 20 ml of blood from
the tail vein (as for peripheral blood microfilaremia) or 50 ml from the
heart (at necropsy, as for cardiopulmonary microfilaremia) were processed
for a thick smear through a scratch method and slides were then stained
with 40% Giemsa.
Flow cytometry
After parasite enumeration and removal, peritoneal exudates were centri-
fuged (250 G, 5 min, 4˚C), and cells were resuspended in 1 ml FACS buffer
(PBS, 5% FCS, and 1 mM EDTA). Total cell counts were performed in
PBS/0.04% trypan blue (Sigma-Aldrich) using a hemocytometer (KOVA
Glasstic Slide). Proportions of most of the different leukocyte populations
were determined by flow cytometry using the following rat anti-mouse
Abs: anti-F4/80–BV711 (clone BM8; BioLegend), anti–Siglec F PE
(clone E50-2440; BD), anti–Ly-6G–BV650 (clone 1A8; BioLegend), anti-
B220–PE-Cy5 (clone RA3-6B2; eBioscience), anti-CD3–AF700 (clone
17A2; eBioscience), anti-IgE–FITC (clone 23G3; Invitrogen), and anti-
CD49b–APC (clone DX5; eBioscience). For innate lymphoid cell pop-
ulations, a lineage mixture comprised anti-CD8 (clone 53-6.7; eBioscience),
anti-B220 (clone RA3-6B2; eBioscience), anti-F4/80 (clone BM8; eBio-
science), anti–Siglec F (clone ES22-10D8; Miltenyi Biotec), anti-CD4
(clone GK1.5; eBioscience), anti–Ly-6G (clone RB6-8C5; eBioscience),
and anti-FcƐR1 (clone MAR-1; eBioscience) Abs conjugated to APC were
used in combination with anti-ST2–PE (clone RMST2-2; eBioscience), anti-
NKp46–AF700 (clone 29A1.4; BD), anti–IL-12Rb2–AF488 (clone 305719;
R&D), and anti–CD127 PerCP-Cy5.5 (clone A7R34; eBioscience). Eosin-
ophil activation markers panel comprised anti-F4/80–BV711 (clone BM8;
BioLegend), anti–Siglec F APC (clone REA798; Miltenyi Biotec), anti-
CD28–PE-Cy7 (clone 37.51; Thermo Fisher Scientific), anti–MHC class II
(MHCII)–AF700 (clone M5/114.15.2; Thermo Fisher Scientific), anti-
CD86–BV605 (clone GL-1; BioLegend), anti-CD69–APC eF780 (clone
H1.2F3; Thermo Fisher Scientific), and anti-CCR3–PE (clone J073E5;
BioLegend) Abs. All panels included a viability staining using the eF450
viability dye (Invitrogen), and all Abs were used at a 1/40 dilution. Repre-
sentative gating strategies are given in Supplemental Figs. 1, 2. Flow cyto-
metric acquisition was performed on a BD LSR II and data analyzed on
FlowJo Software (version 10.0.7).
Statistical analysis
Statistical analysis was carried out using GraphPad Prism v8. Sample size,
normality (Shapiro–Wilk test), and homoscedasticity (Bartlett test) were
tested prior to further analysis. Data from two to three separate experi-
ments were pooled when possible. Significant differences between groups
were evaluated by either t test (two groups) or Mann–Whitney (more than
two groups) or Kruskal–Wallis with Dunn post hoc tests (more than two
groups). Significance was defined as *p , 0.05, **p , 0.01, ***p ,
0.001, and ****p , 0.0001.
Results
IL-4Ra–independent immunity is sufficient for protection
against chronic adult B. malayi infection
Recently, we have defined a mechanism of adaptive immune
control against invading B. malayi filarial larvae that is mediated
by IL-4–IL-4R alternative activation of peritoneal macrophages
and resultant CCR3-dependent tissue eosinophilia (18). Key tim-
ings of the B. malayi life cycle developmental stages in mice are:
third–fourth stage larvals molt around days 7–10, fourth stage
larvals–adult stage molt around 4–5 wk, and mf release from fe-
males at the site of infection (patent phase) from week 11 on-
wards. We thus examined IL-4Ra2/2 mouse susceptibility to
immature (prefecund) adult B. malayi starting at 5 wk postinfec-
tion (Fig. 1A) when the majority of wild-type (WT) mice have
cleared infections at a point preceding adult development (11, 18,
21). Because severe-combined lymphopenic strains lacking
functional adaptive immunity are fully susceptible to chronic
patent B. malayi infections (11, 18, 19, 21–24), we therefore
scrutinized whether specific deficiency in IL-4Ra signaling was
sufficient to also allow progression of development of B. malayi
adults toward an early fecund time-point of 11 wk postinfection
FIGURE 1. Gradual waning of patent adult worm
infections in B. malayi–infected IL-4Ra2/2 mice. (A)
Parasite recovery at 2, 5, 9, and 11 wk after B. malayi
infection in IL-4Ra2/2 mice. Kruskal–Wallis one-way
ANOVA followed by Dunn multiple comparisons test
(n = 9), two individual experiments). *p , 0.05, ***p
, 0.001, ****p , 0.0001. (B) mf release in the peri-
toneal cavity of IL-4Ra2/2–infected mice at readout
11 wk postinfection (n = 9), two individual experiments.
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(Fig. 1A). During time course infection experiments, although
infection is beginning to be cleared in WT animals at 5 wk
postinfection (mean 2% parasite recovery and sterilizing immu-
nity evident in ∼50% of animals) (18), 9/10 IL-4Ra2/2 mice
contained adult B. malayi, and levels of motile parasites were not
significantly different to numbers of surviving larvae at 2 wk
postinfection (Fig. 1A). At 9 wk postinfection, 5/10 mice had no
evidence of infection, and yields of recovered adults were sig-
nificantly reduced compared with 2-wk larval yields (median yield
of 2 versus 22 B. malayi; Kruskal–Wallis one-way ANOVA sta-
tistic 28.4; p , 0.001 Dunn multiple comparisons test). By 11 wk
postinfection infections are resolved in WT mice (18). Similarly,
the majority of IL-4Ra2/2 mice (6/9) were infection negative, and
levels of surviving adults were significantly reduced compared
with larval burdens at 2 wk or adult loads at 5 wk (median yield of
0 versus 22 B. malayi at 2 wk, p , 0.0001; or versus 10 B. malayi
at 5 wk, p , 0.05). mf production was only detected in 2/9 mice
at 11 wk in 2/3 mice with active adult infection (Fig. 1B), indi-
cating that sterile cure of adult B. malayi had occurred in the
majority of IL-4Ra2/2 mice at a point prior to establishment of
fecund infections.
IL-4Ra–independent immunity to fecund adult B. malayi is
associated with a residual CCR3-mediated eosinophilia
Because immune resistance to filarial infection is dependent on a
sustained influx of eosinophils mediated by the CCR3-CCR3
ligand chemokine pathway (1, 4, 11, 18, 21), the levels of
Siglec F+ eosinophils in the peritoneal infection site were com-
pared between WT, IL-4Ra2/2, and CCR32/2 mice (Fig. 2A,
2B). At 2 wk postinfection, corresponding with initial larval
B. malayi establishment, median levels of eosinophils were ele-
vated .30-fold compared with naive basal levels in the peritonea
in BALB/c WT mice (median level: 3.03 3 106 at 2 wk post-
infection versus 0.09 3 106 in naive mice; Fig. 2B). Contrast-
ingly, eosinophilia was not apparent in infected CCR32/2 mice
(median level: 0.04 3 106). In comparison, IL-4Ra2/2 mice
exhibited a suboptimal eosinophilia 2 wk postinfection, which
despite being .9-fold significantly impaired compared with WT
mice, was nonetheless significantly elevated compared with
CCR32/2 animals (0.36 3 106 median level, Kruskal–Wallis
one-way ANOVA statistic: 41, p , 0.01 compared with WT or
CCR32/2 mice, Dunn multiple comparisons tests; Fig. 2B). The
residual eosinophilia was maintained throughout the time course
of infection in IL-4Ra2/2 mice and was significantly elevated
compared with corresponding CCR32/2-infected animals at 5
wk (p = 0.05) or 12 wk postinfection (p = 0.05; Dunn multiple
comparisons tests; Fig. 2B). To determine whether this residual
eosinophil population in IL-4Ra2/2 mice was immunopheno-
typically different to the one of their WT mice counterparts, we
examined eosinophil-related CCR3, CD28, MHCII, CD86,
CD69, and RELMa markers expressions in WT and IL-4Ra
knockout mice at 14 d postinfection (Supplemental Fig. 2). We
did not detect any significant differences in eosinophil pheno-
types in the absence of IL-4R signaling, suggesting that these
eosinophils populations are not immunologically different. To
find out whether residual eosinophil recruitment was impor-
tant in mediating gradual immune-dependent attrition of adult
B. malayi in the face of IL-4R deficiency, we depleted eosinophils
using a rat monoclonal anti-(a)CCR3 Ab treatment known to
transiently ablate mature eosinophil populations, including
those recruited to sterile sites of filarial infection (18, 25, 26).
Groups of mice were administered with aCCR3 or rat isotype
control every 2 wk, commencing from the point of infection with
B. malayi larvae (Fig. 2C). One week following the final dose, at
5 wk postinfection, levels of eosinophils were significantly re-
duced (by .4-fold) in the peritonea of infected, aCCR3-treated
IL-4Ra2/2 mice compared with isotype-treated infection controls
(from 0.398 3 106 to 0.085 3 106 mean levels, respectively,
Kruskal–Wallis one-way ANOVA statistic: 80.61, Dunn multiple
comparisons tests, p , 0.05; Fig. 2D, 2E). By comprehensive
immunophenotyping, all other major populations of leukocytes in
the peritonea of infected IL-4Ra2/2 mice were found to be un-
perturbed by the course of Ab treatment (Fig. 2E). The impact of
serial aCCR3 treatments and eosinophil ablations was a signifi-
cant increase in the yield of immature B. malayi adults at 5 wk
postinfection (mean worm recovery rate of 4.2 and 15.5 for control
and treated mice, respectively, Student t test, t: 2.843, p = 0.0217;
Fig. 2F).
In a complementary approach, and because it was not possible
to sustainably administer Ab treatments for longer than a 5-wk
period, we created an IL-4Ra2/2CCR32/2 double-knockout
mouse on the BALB/c background. This enabled us to further
scrutinize whether IL-4Ra2/2–independent sterilizing immunity
required CCR3-mediated recruitment of peritoneal eosinophils.
At 12 wk postinfection (Fig. 3), eosinophilia was significantly
impinged in IL-4Ra2/2CCR32/2 double-knockout mice com-
pared with WT infections, whereas as IL-4Ra2/2 mice exhibited
an intermediate eosinophilia that was not significantly inferior to
eosinophil levels in WT mice (median eosinophil levels of 0.52 3
106, 0.087 3 106, and 0.05 3 106 for WT, IL-4Ra2/2, and
IL-4Ra2/2CCR32/2 mice, respectively; Kruskal–Wallis one-way
ANOVA statistic 10.3, p, 0.01; Fig. 3A, 3B). In WTand IL-4Ra2/2
groups, the majority of mice had no evidence of active adult
infection (9/11, WT; and 6/10, IL-4Ra2/2), and remaining infected
animals contained a single live adult B. malayi. In comparison, a
significantly higher proportion (9/11) of IL-4Ra2/2CCR32/2
double-knockout mice yielded adult worm infections (x2 statistic:
70.61, p, 0.0001; Fig. 3C, 3D). The resultant B. malayi burden in
IL-4Ra2/2CCR32/2 mice was significantly increased compared
with WT or IL-4Ra2/2 groups (median percentage recovery of 8,
range 0–42, Kruskal–Wallis one-way ANOVA statistic: 14.2, p ,
0.05 versus WT mice, p , 0.01 versus IL-4Ra2/2 mice, Dunn
multiple comparisons tests; Fig. 3D). Further, B. malayi fecund
infections were evident in (7/11) IL-4Ra2/2CCR32/2 mice ver-
sus 4/11 IL-4Ra2/2 mice and 1/10 WT mice (Fig. 3E). Levels of
mf production in the peritonea of IL-4Ra2/2CCR32/2 mice were
significantly elevated compared with WT mice (median 17 3 103
peritoneal mf versus 0, Kruskal–Wallis one-way ANOVA statistic
9.5, p , 0.01, Dunn multiple comparisons test; Fig. 3E). There-
fore, our infection model indicated CCR3-dependent processes
and recruitment of residual eosinophilia were sufficient to exert
immune control of fecund infections in the absence of IL-4R
signaling.
IL-5 is critical in the regulation of residual eosinophilia
and immunity against adult B. malayi in the absence of
IL-4R signaling
IL-5 is important in the immune control of filarial infection (27–30).
We and others have shown that Brugia experimental infections
stimulate high levels of IL-5 systemic responses (18, 21, 31). IL-5
is a promoter, survival, and chemotactic factor for eosinophils
(1, 27, 32). To explore whether IL-5 was a necessary component of
IL-4Ra2/2–independent immunity to adult filarial infection, we
compared susceptibility at the fecund adult stage 12 wk postin-
fection in WT, IL-4Ra2/2, and IL-4Ra2/2IL-52/2 mice (Fig. 4,
Supplemental Fig. 2). We determined eosinophilia was profoundly
impaired in IL-4Ra2/2IL-52/2 mice compared with either WT or
the residual eosinophil level in IL-4Ra2/2mice (median eosinophilia
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FIGURE 2. Temporal ablation of residual eosinophilia enhances survival of B. malayi adult infection in IL-4Ra2/2 mice. (A) Representative flow
cytometry plots for eosinophils phenotyping based on their Siglec F marker expression (Siglec F+ and F4/80low) 12 wk postinfection in infection WT,
IL-4Ra2/2, and CCR32/2 mice. (B) Peritoneal eosinophil numbers in either WT, IL-4Ra2/2, or CCR32/2 mice at 2, 5, and 12 wk after B. malayi in-
fection. Kruskal–Wallis one-way ANOVAwith Dunn multiple comparisons tests or Mann–Whitney tests (n = 5–15), one to two individual experiments. The
area within the two dashed lines represents62-fold change of WT naive peritoneal eosinophil levels, and data falling above the gray area indicate increased
eosinophil numbers compared with WT naive mice. *p, 0.05, **p, 0.01. (C) Schematic representation of the study design for temporal CCR3-dependent
eosinophilia ablation using an anti-aCCR3 blocking Ab. (D) Representative plots of blood and peritoneal eosinophils (Figure legend continues)
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0.02 3 106 versus 0.7 3 106, WT or 0.18 3 106, IL-4Ra2/2,
Kruskal–Wallis one-way ANOVA statistic: 21.5, p, 0.001 or p, 0.
05, Dunn multiple comparisons tests; Fig. 4A, 4B). The majority of
IL-4Ra2/2IL-52/2 mice contained active adult worm infections and
frequency of infection was significantly higher compared with WTor
IL-4Ra2/2 mice (15/18 mice, versus 5/19 WT and 6/16 IL-4Ra2/2
mice, x2 statistic: 70.61, p, 0.0001; Fig. 4C). Adult B. malayi worm
burdens were significantly higher in IL-4Ra2/2IL-52/2 mice com-
pared with either WT or IL-4Ra2/2 animals (median percentage
recovery 16 versus 0 in both WTor IL-4Ra2/2mice, Kruskal–Wallis
one-way ANOVA statistic: 22.4, p , 0.001 or p , 0.01, Dunn
multiple comparisons tests; Fig. 4D). Fecundity, measured by pres-
ence of motile peritoneal mf, was discernable in 13/18 IL-4Ra2/2IL-
52/2 mice, 3/19 WT mice, and 7/16 IL-4Ra2/2 mice. The yields of
mf produced were significantly higher in IL-4Ra2/2IL-52/2 mice
than either WT or IL-4Ra2/2 animals (median mf count 13 3 104
versus 0 for both WT and IL-4Ra2/2 groups, Kruskal–Wallis one-
way ANOVA statistic: 19.3, p, 0.001 versus WTor p, 0.05 versus
IL-4Ra2/2, Dunn multiple comparisons tests; Fig. 4E).
Deficiency in IL-4R signaling alone or combined with
deficiency in CCR3 or IL-5 does not influence
microfilarial infection
We defined that IL-4R–independent, CCR3, and IL-5 eosinophil
recruitment processes limited patent adult filarial infections. In the
minority of IL-4Ra2/2 mice featuring active fecund infection,
yields of mf produced were lower, either reflecting an indirect
effect of reduced adult burdens or, alternatively, that IL-4Ra–in-
dependent processes were also directly affecting mf survival.
Because distinct immune responses are triggered against different
life cycle stages of filarial parasites (1, 10, 29, 33, 34), we scru-
tinized whether either IL-4R–dependent or IL-4R–independent/
CCR3- or IL-5–dependent immunity was also operating at the
level of stage-specific mf infections. We infused mice with 0.25 3
106 motile B. malayi mf and analyzed circulating parasitemias
over a time course of 28 d. Microfilaremias were stable in WT
mice over the time course (Fig. 5A). No significant increases
were apparent in circulating parasitemias at any time-point
within IL-4Ra2/2, IL-4Ra2/2CCR32/2, or IL-4Ra2/2IL-52/2
mice compared with WT controls. Because the majority of sur-
viving infused B. malayi mf sequester in the cardiopulmonary
circulation (19, 20), the levels of mf in cardiac blood at termi-
nation were also evaluated (Fig. 5B). Similar microfilaremias
were recorded between WTand IL-4Ra2/2, IL-4Ra2/2CCR32/2,
or IL-4Ra2/2IL-52/2 mice, indicating that these immunodefi-
ciencies did not have any impact on mf parasitism in the blood
during the first 4 wk of a primary infection.
Discussion
A high degree of compensatory pathways and functional redun-
dancy are apparent in Th2 immunity. In the current study, we
reinforce the primary role of eosinophilia in driving immune
control of adult filarial nematode infection, yet demonstrate that
eosinophil-mediated immune resistance can proceed in the absence
of IL-4R signaling. We demonstrate that a residual eosinophilia
occurs in B. malayi–infected IL-4Ra2/2 mice, which we suc-
cessfully targeted via serial treatment with anti-aCCR3 depleting
Ab. This ablating Ab treatment did not impact on any other local
effector immune cell type examined and led to an increased sus-
ceptibility to B. malayi infection.
IL-4 and IL-13 are drivers of key hallmarks associated with type-
2 inflammation (18, 35, 36). Both il-4 and il-13 gene activation
can be mediated through the IL-4Ra (37). Both cytokines are,
for instance, critical for helminth infection-associated intestinal
mucus production (38, 39), Trichinella spiralis–dependent host
inducible nitric oxide synthase expression (40, 41), positive reg-
ulation of the Foxp3+ T cell populations with the tissue-dwelling
parasites Schistosoma mansoni and Nippostrongylus brasiliensis
(42), and optimal Heligmosomoides polygyrus expulsion (43). In
the context of filariasis, IL-4 and IL-13 have been described as
critical cytokines required for the expansion of tissue-resident
macrophages that optimally maintain eosinophilic influx and
effector responses at the site of infection (18, 26). Nonetheless,
IL-4/IL-13 helminth-associated immune mechanisms are para-
site species specific with, for example, goblet cell hyperplasia
impairment observed with N. brasiliensis experimental infec-
tions in IL-4Ra2/2 mice, but not with Syphacia obvelata and
S. mansoni infection settings (39). Our present study also indicates
other host-derived mechanisms or cytokines can partially compen-
sate the absence of IL-4R signaling to exert Th2 immunity (36). It
has been shown that several cytokines such as TNF-a, IL-1, and
TGF-b can contribute to CCL11 production in a context of IL-4Ra
deficiency (44). We and others have previously shown that macro-
phage CCR3 ligand expression (CCL8, CCL11, and CCL24) is
upregulated during filarial infection and that macrophages are es-
sential for maintaining eosinophil recruitment into the peritoneal
cavity (18, 45). During type 2 inflammation, in the absence of
IL-4R, other macrophage ligand–receptor-activating signals have
been implicated in macrophage proliferation or alternative activa-
tion, such as IL-10, IL-33, and Ig (45–47). Thus, it is possible that
IL-4R–independent macrophage activation during chronic filarial
infection supports suboptimal eosinophil recruitments sufficient for
protection against adult B. malayi infection.
Eosinophilia at tissue sites of inflammation can be mediated by a
number of distinct molecules or pathways, including ILs such as
IL-2, IL-3, and IL-5; growth factors, such as (G)M-CSF; che-
mokines such as CCL5, 11, 24, and 26; and leukotrienes, such as
leukotriene B4 (48, 49). Our data indicate that both CCR3-
dependent ligands and IL-5 are necessary to induce eosinophilia
to filarial infection in the absence of IL-4R signaling. This may
reflect that IL-5 signaling is fundamental to support CCR3 che-
motaxis to the peritoneal site of filarial infection. Certainly, in-
creased expression of CCR3 is demonstrable in IL-5–activated
eosinophils and augments eotaxin (CCL-11)–mediated eosinophil
chemotaxis in vitro (50). Alternatively, IL-5 may be working as an
independent chemotactic factor by which both IL-5R ligation and
CCR-3 ligation are nonredundant signals combining to mediate
peritoneal tissue eosinophilia in response to filarial parasitism. A
recent study with L. sigmodontis infections comparing IL-4Ra2/2
with IL-4Ra2/2IL-52/2 combined deficiency also recorded re-
sidual eosinophilia in IL-4Ra–deficient mice, which was ablated
when compound IL-5 deficiency was introduced and was signifi-
cantly related to increased susceptibility to fecund adult infections
(19). IL-5 residual immune responses also are important in the
successful ablation at 2 wk after anti-aCCR3 blocking Ab injection at 0.5 mg in IL-4Ra2/2 mice (n = 4). (E) Comparative peritoneal cell population
numbers at 5 wk postinfection in infected IL-4Ra2/2 mice and either treated with anti-aCCR3 blocking Ab (Rx) or its respective isotype control (Ctrl).
Kruskal–Wallis one-way ANOVAwith Dunn multiple comparisons tests (n = 5), single experiment. *p , 0.05. (F) Parasitical readout at 5 wk postinfection
in IL-4Ra2/2 mice injected either with Rx or its Ctrl. t Test, (n = 5), single experiment. *p , 0.05.
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FIGURE 3. CCR3 signaling is required for residual eosinophilia and resistance to chronic fecund B. malayi infection in IL-4R–deficient mice.
(A) Representative flow cytometry plots for eosinophils and macrophages phenotyping based on their Siglec F and F4/80 respective marker expression (eo-
sinophils being Siglec F+ F4/80low, whereas macrophages are Siglec Flow F4/80+) at 12 wk postinfection in infected WT, IL-4Ra2/2, and IL-4Ra2/2CCR32/2
mice. (B) Comparative peritoneal eosinophilia at 12 wk after B. malayi infection in WT, IL-4Ra2/2, and IL-4Ra2/2CCR32/2 mice. Kruskal–Wallis one-way
ANOVA followed by Dunn multiple comparisons tests (n = 10–11), two individual experiments. **p , 0.01. (C) Percentage of mice still infected 12 wk after
third-stage infectious larvae inoculations x2 analysis, p , 0.0001, n = 10–11, two individual experiments. (D) Worm recoveries at 12 wk postinfection in
infected WT, IL-4Ra2/2, and IL-4Ra2/2CCR32/2 mice. Kruskal–Wallis one-way ANOVAwith Dunn multiple comparisons tests or Mann–Whitney tests (n =
10–11), two individual experiments. **p , 0.01. (E) mf release in the peritoneal cavity of infected WT, IL-4Ra2/2, and IL-4Ra2/2CCR32/2 mice at 12 wk
postinfection. Kruskal–Wallis one-way ANOVA followed by Dunn multiple comparisons tests (n = 10–11), two individual experiments. **p , 0.0.
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FIGURE 4. IL-5 is required for residual eosinophilia and resistance to chronic fecund B. malayi infection in IL-4R–deficient mice. (A) Representative
flow cytometry plots for eosinophil and macrophage phenotyping based on their Siglec F and F4/80 respective marker expression 12 wk postinfection in
infected WT, IL-4Ra2/2, and IL-4Ra2/2IL-52/2 mice. (B) Comparative peritoneal eosinophil at 12 wk after B. malayi infection in WT, IL-4Ra2/2, and
IL-4Ra2/2IL-52/2 mice. Kruskal–Wallis one-way ANOVA followed by Dunn multiple comparisons tests (n = 16–19), three individual experiments. *p ,
0.05, ***p , 0.001. (C) Percentage of mice still infected 12 wk after third-stage infectious larvae inoculations x2 analysis, p , 0.0001 (n = 16–19), three
individual experiments. (D) Worms recoveries at 12 wk postinfection in infected WT, IL-4Ra2/2, and IL-4Ra2/2IL-52/2 mice. Kruskal–Wallis one-way
ANOVAwith Dunn multiple comparisons tests or Mann–Whitney tests (n = 16–19), three individual experiments. **p, 0.01, ***p, 0.001. (E) mf release
in the peritoneal cavity of infected WT, IL-4Ra2/2, and IL-4Ra2/2IL-52/2 mice at 12 wk postinfection. Kruskal–Wallis one-way ANOVA followed by
Dunn multiple comparisons tests (n = 16–19), three individual experiments. *p , 0.05, ***p , 0.001.
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control of juvenile adult development of the related human filaria
Loa loa during IL-4Ra deficiency (51).
Beyond activation and recruitment to the site of infection, both
CCR3 ligands and/or IL-5 may augment tissue eosinophil survival.
Following N. brasiliensis or T. spiralis infection, the rate of eosin-
ophil production in the bone marrow is unaltered, whereas pro-
nounced eosinophilia is recorded in several tissues, suggesting that
recruited eosinophil survival is increased (52, 53). Murine eosino-
phils migrating to the peritoneum could recirculate to other organs,
thus indicating the peritoneum as a reservoir for eosinophils (52).
Eosinophils have prior been defined as an essential effector cell
component of the antifilarial immune response against various
filarial parasite life cycle stages in vitro and in vivo (54), including
an active involvement in direct mf killing (2, 55), in granulocytic
content release at the site of infection (2, 4, 56), mf-targeted Ab-
dependent cytotoxicity mechanisms (55, 57), and granuloma
clustering around infective and adult stages (10, 12, 58). Our
present study illustrates that whereas a muted eosinophil response
is evident in the absence of IL-4/IL-13 signaling, low eosinophilia
is still an integral component of immune attrition to juvenile
adults in IL-4Ra mice. We further characterized eosinophils from
IL-4Ra2/2 mice and compared them to their WT mice–derived
counterparts. We analyzed the expression profiles of the well-
defined and inflammation or parasitic infection-driven pheno-
typic markers, such as the systemic highly upregulated CD86 and
CD69 markers (59–61), the blood highly upregulated CD28
marker (59, 60); the lung, blood, and bone marrow upregulated
MHCII and RELMa markers (59, 62, 63); and the peritoneum,
bone marrow and blood downregulated CCR3 marker (64, 65).
Interestingly, expression profiles were very similar, suggesting that
these eosinophils populations are not immunologically different.
Contrastingly, we did not observe any alterations in circulating
B. malayi microfilaremias in either IL-4Ra2/2 or IL-4Ra2/2CCR32/2
or IL-4Ra2/2IL-52/2 mice compared with WT controls for a
period of up to 4 wk following infusion. This may indicate that
these eosinophil recruitment and survival responses are not im-
portant in the control of B. malayi filarial microfilaremias in the
circulation or the spleen. This may appear contradictory with prior
work, demonstrating that control of B. malayi microfilaremias
require CCL-11, eosinophil production, and eosinophil specific
granule products (2, 66, 67). However, prior work has shown that
deficiency in the CCR3 ligand, CCL-11, renders mice more sus-
ceptible to persistent microfilaremias after 49 d (66). It is therefore
possible that longer-term primary infections might resolve the
relative roles of IL-4Ra, IL-5, and CCR3 in eosinophil-mediated
control of circulating mf.
The major cellular sources of CCR3 ligands and IL-5 supporting
IL-4Ra–independent, eosinophil-mediated immunity to B. malayi
was not examined in this study. In the context of helminth in-
fection, IL-5 is known to be produced not only by CD4+ T cells
but also type 2 innate lymphoid cells (68, 69). In our system, ILC
population levels at the site of parasitism were similar between IL-
4R–sufficient and –deficient animals at 12 wk postinfection
(Supplemental Fig. 3). If IL-4R–independent immune mecha-
nisms occur in the natural human host, targeting of a non–IL-4/IL-
13–dependent eosinophilic immune pathway may be of potential
benefit in a vaccination approach to derisk the generation of severe
anaphylactic, IgE-mediated side effects.
Beyond basic immunobiology, the identification of eosinophilic
control of patent adult B. malayi infection and its successful ma-
nipulation by compound IL-4Ra2/2CCR32/2 or IL-4Ra2/2IL-52/2
deficiencies offers new selective knockout research models for
translational filariasis research. One advantage of a refined selective
knockout system, over lymphopenic models currently in use (20, 21),
is the maintenance of more realistic serological components (im-
munoglobulins, immune-complexes, and complement) that may
otherwise cause artefacts in the discovery of novel filarial biomarkers.
In summary, our data confirm the pivotal role of eosinophils in
the control of the filarial infection and reinforces the importance of
CCR3-dependent eosinophilia in mediating immunity to the human
filarial pathogen, B. malayi (18). Although IL-4R–dependent re-
sponses are necessary for rapid eosinophil-mediated primary im-
munity to establishing filarial larvae, we reveal that a layer of
redundancy exists so that IL-4/13–independent and IL-5– and
CCR3-dependent processes can compensate and more gradually
exert immune killing to prefecund adult infections by mediation of
a modified eosinophil recruitment.
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